Back to profiles

Koby Elias

Greater Salt Lake City Area

Upon earning my B.S. in Chemistry from Union College I accepted a position as a the seventh employee at a bio-technology start-up; Semprus Biosciences in Cambridge, MA. Through my various roles at Semprus, I was exposed to the entire arc of a start-up: proof-of-concept R&D, fundraising milestones totaling $28M in VC funding, manufacturing process development, an FDA 510k submission and approval, and finally an acquisition of Semprus by Teleflex Medical for $80M.

Expert
$1.50/min
(0)
Request a Call

On-demand, expert advice.

Areas of Expertise

  • Pilot Scale Manufacturing Process Development

    • Developed a new blood-compatible medical device surface that received FDA and CE Mark regulatory approval, allowing Semprus Biosciences to be purchased by Teleflex Inc. for $80M • Conducted, analyzed, and presented research used to raise $18M in Series B venture capital funding

    • Manufacturing
    • Prototypes
    • Vascular Access
    • Biomaterials
    • Thrombosis
    • Quality System

My Interests

Health Sectors
Medical Devices, Biotech

Experience

  • Process Engineer

    Semprus BioSciences | July 2011 - May 2013

    • Collaborated with a team of engineers to develop a polymer surface modification for a Peripherally Inserted Central Catheter (PICC) that received FDA 510(k) approval and CE mark certification, allowing Semprus Biosciences to be purchased by Teleflex Inc. for $80M • Conducted, analyzed, and presented research used to raise $18M in Series B venture capital funding • Successfully integrated with the Teleflex team and applied our modification process to their suite of vascular access products • Contributed to the entire arc of product development from earliest stage R&D through pilot scale manufacturing and regulatory approval • Fostered constructive dialogue between the Chemistry and Process Development groups within Semprus

  • Research Associate

    Semprus BioSciences | June 2010 - July 2011

    • Executed and distilled proof-of-concept research crucial to securing a $1M Department of Defense grant to develop anti-microbial orthopedic devices • Cooperated on development of a drug-leaching polymer layer to augment our surface modification. Personally responsible for establishing drug release rate out of polymer layer • Work was published in the Journal of Orthopedic Trauma and presented at the Orthopedic Trauma Assoc. Conference as well at the Military Health Research Symposium

  • Research Intern

    Semprus BioSciences | June 2009 - September 2009

    • Worked on a research team that produced the technological foundation of the company and secured $6M in Series A funding • Synthesized non-fouling polymer on various medically relevant substrates like titanium and polyurethane • Assisted in operations including lab equipment inventory and documentation

Education

  • University of Utah - David Eccles School of Business

    Master of Business Administration (MBA) | Entrepreneurship/Entrepreneurial Studies | 2014 - 2016

  • Union College

    BS | Chemistry | 2006 - 2010